The applications of curcumin have been limited by its poor water solubility and low bioavailability. In this study, we successfully synthesized a new curcumin derivative, curcumin-8'-O-4''-O-methyl-β-D-glucopyranoside, by biotransformation with the fungal strain Beauveria bassiana ATCC 7159. The structure of this new product was determined on the basis of spectroscopic data. This is the first record of a curcumin glycoside that has been synthesized by a fungus.
derived from the rhizome of Curcuma longa, is the major bioactive component of turmeric, which has long been used in traditional Asian medicine to treat diseases such as gastrointestinal upset and arthritic pain. Numerous research on curcuminoids has been conducted and revealed that 1 has a variety of pharmacological properties, such as anti-inflammatory, antidepressant, antitumor, antioxidant, antiproliferative, antiangiogenic, antimicrobial, hepatoprotective, and nephroprotective activities [1] [2] [3] [4] [5] [6] [7] . These significant biological activities make 1 a promising drug candidate for the treatment of different diseases. However, clinical trials of 1 are hampered by its poor bioavailability and low solubility in water [8] . Many approaches have been attempted to overcome these disadvantages, such as using nanoparticle encapsulation for rendering it dispersible in aqueous media [9] . Glycosylation has also emerged as an effective way of enhancing the water solubility of curcuminoids. For example, 1 was metabolized by Catharanthus roseus cells, from which a series of unnatural glycosides of curcumin were produced. The water solubility of one of the products, curcumin-4',4''-O-β-D-digentiobioside was 0.65 mmol/mL, which was 20 million-fold higher than that of 1 [10] .
Microorganisms and their enzymes are increasingly being used as biocatalysts to alter the structures of organic compounds. In a study of the microbial metabolism of 1, the substrate was converted into six reduced and demethoxylated products by Pichia anomala ATCC 20170, among which four were characterized based on their spectral data. However, preparation of curcumin glycosides through microbial transformation has not been achieved yet. Beauveria bassiana ATCC 7159 is a fungus which contains abundant enzymes with broad substrate specificity and has been widely used for the biotransformation of over 160 substrates [11] . A variety of enzymatic reactions by this fungus have been reported, such as hydroxylation of saturated and aromatic carbon, keto-alcohol reduction and oxidation reactions, alkene reduction and oxidation, sulfide oxidation, Baeyer-Villiger oxidations, conjugation reactions, hydrolysis of epoxides and esters, heteroatom dealkylation, and reduction of peroxides to alcohols [11] . In our previous work, we successfully used B. bassiana as a whole-cell biocatalyst to modify a series of phenolic natural products to produce new 4'-Omethylglucosides [12] [13] [14] [15] . Since the structure of 1 has two aromatic rings with one free phenol group on each, we reasoned that this fungus may be able to catalyze a similar glycosylation and attach a sugar moiety to the phenol group(s) of 1, resulting in more water soluble curcumin glycosides. Thus, we decided to carry out a Commercial curcumin is a mixture of three curcuminoids, including 1, desmethoxycurcumin (2) and bisdesmethoxycurcumin (3). To begin the biotransformation experiment, we first isolated 1 from the mixture using high performance liquid chromatography (HPLC). This pure compound was then used as the substrate for our small scale biotransformation experiments. The extracts from the mycelium and filtrate were analyzed by HPLC. In addition to 1, a new peak (4) with the same UV absorption pattern was detected at 16.2 min. Compound 4 has a shorter retention time than the substrate on reversed-phase HPLC, indicating that a more polar product was formed from this biotransformation process.
In order to identify the structure of 4, we scaled up the biotransformation experiment. Compound 4 was isolated in pure form with a yield of 20.3%. The [M+H] + ion at m/z 545.2021 in the HRTOFESMS showed that 4 had a molecular formula of C 28 H 32 O 11 , suggesting that a 4'-O-methyl-glucose unit had been introduced into the molecule of the substrate. This was supported by the occurrence of seven new carbon signals in the 13 C NMR spectrum in addition to the 21 signals from the substrate, including five methine carbon (CH) resonances at δ 99.7, 73.8, 77.0, 79.4, and 76.1, one methylene carbon (CH 2 ) at δ 60.6, and one methoxy (OCH 3 ) at δ 60.0. The corresponding proton signals of this 4'-O-methyl-glucose moiety were also observed in the 1 H NMR spectrum ( Table 1 ). All these data were perfectly consistent with those of the 4'-Omethyl-D-glucose moiety previously reported [12] [13] [14] [15] [16] , thus allowing us to conclude that this new product is a 4'-O-methylglycosylation product of 1. The connection of the sugar moiety to the aglycon was established by the HMBC correlation of 1"-H (δ 4.99) to C-8' (δ 148.5) ( Figure 1 ). Therefore, based on 1D-and 2D-NMR spectroscopic data, compound 4 was identified as
All the proton and carbon signals were assigned and are listed in Table 1 .
Recently, curcumin-β-diglucoside was chemically prepared and its biological activities reported. In addition to significantly improved water solubility (10 mg/mL), this compound displayed stronger radical-scavenging and antioxidant properties than 1. Curcumin-β-diglucoside also showed higher antibacterial activity against Staphylococcus aureus and Escherichia coli, but lower activity against Bacillus cereus and Yersinia enterocolitica than 1. Both compounds had comparable activity in the antimutagenicity studies. All these results demonstrated that conjugation of the phenolic hydroxyl group to a sugar moiety made it more water-soluble while either retaining or enhancing the biological properties [17] . Compound 4 is a new compound and its water solubility was found to be 39,000-fold higher than 1. Encouraged by the improved activities of curcumin-β-diglucoside, we will evaluate the biological activities of 4 in our future studies.
To the best of our knowledge, although the syntheses of glycosides of curcumin by plant cell suspension cultures [10] and chemical methods [18] have been reported, this is first time that a new curcumin glycoside has been synthesized by fungal biotransformation. The 4'-Omethyl-glucosylation by B. bassiana ATCC 7159 is more advantageous than chemical methods in that it is an environmentally benign process and requires no toxic chemical reagents. Also, compared with the previously reported plant cell biotransformation of 1, the microbial transformation by B. bassiana is more efficient. According to the report, the plant cells needed at least 12 days to complete the biotransformation process, whereas B. bassiana converted 1 into 4 in 7 days.
In our previous research on the biotransformation of quercetin by B. bassiana [13] , the enzymes responsible for the 4'-O-methylglucosylation were found to be intracellular enzymes, which take the substrate from the medium into the cells. After the enzymatic structural modifications, the product was released from the cells back into the medium. This is consistent with our observation in this study that the substrate and the product were detected in both the mycelium and the filtrate. The preparative scale experiment was carried out in two 2 L flasks, each containing 800 mL PDB under the same conditions as for the small scale experiment. A total of 40 mg of curcumin was used (20 mg/flask).
Extraction, isolation, and identification of the biotransformation product:
The large scale biotransformation broth was filtered through filter paper. The mycelium cake was extracted with 150 mL MeOH, three times, and the filtrate (1.5 L) was extracted with the same volume of 1-butanol twice. The two extracts were combined and evaporated under reduced pressure. The residue was redissolved in 5 mL of DMSO and separated on a Supelcosil LC-PAH column (5 μm, 250 mm × 10 mm) on an Agilent 1200 HPLC instrument. The column was eluted with increasing concentrations of MeOH in H 2 O from 60% to 100% over 11 min, and washed with 100% MeOH for an additional 3 min. The flow rate was 5 mL/min and the compound was detected at 422 nm. The peak at 7 min was collected as the biotransformation product. The product was isolated as a yellow powder and the final yield was 12.0 mg. 
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